Parkinsons Articles

Facing the Beast and Being Honest About My Suffering

Even after years of practicing the Parkinson’s disease self-management program I initiated and developed, which I call “TBM,” I still experience suffering in the form of intense pain, brain fog, and emotionally turbulent days. Still,

https://parkinsonsnewstoday.com/2022/01/21/facing-beast-being-honest-about-parkinsons-suffering

Parkinsons News Today

MJFF Awards 2 Bachmann-Strauss Fellowships in Dystonia Research

A new training program, the Bachmann-Strauss Fellowship in Dystonia Research aims to grow the number of researchers focused on the movement disorder known as dystonia. Launched by the Michael J. Fox Foundation for Parkinson’s Research (MJFF),

https://parkinsonsnewstoday.com/2022/01/21/mjff-awards-bachmann-strauss-fellowship-focus-dystonia-research/

Parkinsons News Today

Regular, Sustained Physical Activity May Help Slow Disease Progression

Regular and sustained physical activity, including daily pursuits such as walking or gardening, may help slow the progression of Parkinson’s in people with early-stage disease, a long-term follow-up study suggests. Patients who exercised regularly over five

https://parkinsonsnewstoday.com/2022/01/21/regular-sustained-physical-activity-may-help-slow-parkinsons-progression/

Parkinsons News Today

Tapering Ropinirole Caused Me Some Scary Side Effects

I’m back! Not just figuratively, but also literally. I recently took some time off to get my health in check. I was in the process of changing medications, and my neurologist had warned me that

https://parkinsonsnewstoday.com/2022/01/20/tapering-ropinirole-scary-side-effects/

Parkinsons News Today

FDA Allows Yumanity to Test Single Doses of YTX-7739

FDA Allows Yumanity to Test Single Doses of YTX-7739

The U.S. Food and Drug Administration (FDA) has issued a partial clinical hold in response to an application by Yumanity Therapeutics requesting permission to begin clinical testing in the U.S. of YTX-7739 for Parkinson’s disease.